Table 1 Baseline characteristics of the study participants by group (N = 36).
Variable | DTT group (n = 8, 4 male 4 Female) | STT group (n = 8, 1 male 7 Female) | p |
|---|---|---|---|
Age (years) | 62.63 ± 5.32 | 63.63 ± 6.48 | 0.635 |
Height (cm) | 161.44 ± 8.52 | 165.75 ± 7.85 | 0.343 |
Weight (kg) | 58.88 ± 7.49* | 69.81 ± 9.16* | 0.035 |
Education level (years) | 13.38 ± 2.33 | 12.75 ± 4.53 | 0.914 |
Montreal cognitive assessment score | 28.13 ± 0.99 | 27.50 ± 1.51 | 0.324 |
disease process (year) | 5.38 ± 3.16 | 5.13 ± 1.55 | 0.709 |
Hoehn and Yahr (stage) | 1.88 ± 0.58 | 2.00 ± 0.71 | 0.698 |
Unified Parkison’s Disease Rating Scale, UPDRS-III | 10.75 ± 2.19 | 11.63 ± 4.59 | 0.916 |
Dopamine equivalent dose (mg/day) | 531.25 ± 146.33 | 576.25 ± 215.60 | 0.46 |